Abstract
Abnormal left ventricular (LV) diastolic relaxation is an early sign of hypertensive heart disease. Whether LV diastolic dysfunction is caused directly by raised blood pressure, or by structural changes related to LV hypertrophy remains controversial. We examined 115 hypertensive patients with LV hypertrophy, and two age- and gender-matched groups (38 hypertensive patients without LV hypertrophy and 38 normotensive subjects) by echocardiography to assess determinants of LV diastolic function, and the relation between diastolic function and LV geometric pattern. Diastolic function was evaluated by the E/A-ratio, E wave deceleration time (E-dec), isovolumic relaxation time (IVRT), and the atrioventricular plane displacement method (AV-LA/AV-mean). A multivariate analysis (including gender, age and body mass index) shows diastolic function to be inversely related to blood pressure, LV wall thickness and LV mass, but not to LV end diastolic diameter. The E/A-ratio generally showed the strongest relations. Only the E/A-ratio and AV-LA/AV-mean were related to heart rate. By stepwise regression analysis, age was the strongest determinant for the E/A-ratio, E-dec and AV-LA/AV-mean, followed by systolic blood pressure, heart rate and LV wall thickness. For IVRT, however, LV wall thickness appeared strongest, followed by systolic blood pressure and age. In conclusion, blood pressure and LV wall thickness both have independent influence on LV diastolic function. Age and blood pressure are the most important factors to determine the E/A-ratio and E-dec, whereas LV geometry and blood pressure are most important when IVRT is used. AV-LA/AV-mean may not be useful in hypertensive LV hypertrophy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Casale PN et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173–178.
Levy D et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566.
Verdecchia P et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97: 48–54.
Koren MJ et al. Left ventricular mass change during treatment and outcome in patients with essential hypertension. Am J Hypertens 2002; 15: 1021–1028.
Koren MJ et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345–352.
Ren JF et al. Doppler echocardiographic evaluation of the spectrum of left ventricular diastolic dysfunction in essential hypertension. Am Heart J 1994; 127: 906–913.
Levy D et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557–1562.
Ishida Y et al. Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure. Circulation 986; 74: 187–196.
Nolan SP, Dixon Jr SH Fisher RD, Morrow AG . The influence of atrial contraction and mitral valve mechanics on ventricular filling. A study of instantaneous mitral valve flow in vivo. Am Heart J 1969; 77: 784–791.
Voutilainen S et al. Factors influencing Doppler indexes of left ventricular filling in healthy persons. Am J Cardiol 1991; 68: 653–659.
Malmqvist K et al. Regression of left ventricular hypertrophy in human hypertension with irbesartan. J Hypertens 2001; 19: 1167–1176.
Remme WJ, Swedberg K . Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527–1560.
Devereux RB, Reichek N . Echocardiographic determination of left ventricular man in man. Anatomical validation of the method. Circulation 1977; 55: 613–618.
Levy D et al. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988; 108: 7–13.
Krumholz HM, Larson M, Levy D . Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995; 25: 879–884.
Schiller NB et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358–367.
Höglund C, Alam M, Thorstrand C . Atrioventricular valve plane displacement in healthy persons. An echocardiographic study. Acta Med Scand 1988; 224: 557–562.
Zaky A, Grabhorn L, Feigenbaum H . Movement of the mitral ring: a study in ultrasoundcardiography. Cardiovasc Res 1967; 1: 121–131.
Alam M, Höglund C . Assessment by echocardiogram of left ventricular diastolic function in healthy subjects using the atrioventricular plane displacement. Am J Cardiol 1992; 69: 565–568.
Agabiti-Rosei E, Muiesan ML . Left ventricular diastolic function in essential hypertension. Contrib Nephrol 1994; 106: 174–178.
de Simone G et al. Relation of left ventricular diastolic properties to systolic function in arterial hypertension. Circulation 2000; 101: 152–157.
Aeschbacher BC et al. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens 2001; 14: 106–113.
Galderisi M et al. Impact of ambulatory blood pressure on left ventricular diastolic dysfunction in uncomplicated arterial systemic hypertension. Am J Cardiol 1996; 77: 597–601.
Genovesi-Ebert A et al. Left ventricular filling: relationship with arterial blood pressure, left ventricular mass, age, heart rate and body build. J Hypertens 1991; 9: 345–353.
Mureddu GF et al. Left ventricular filling in arterial hypertension. Influence of obesity and haemodynamic and structural confounders. Hypertension 1997; 29: 544–550.
Galderisi M et al. Impact of heart rate and PR interval on Doppler indexes of left ventricular diastolic filling in an elderly cohort (the Framingham Heart Study). Am J Cardiol 1993; 72: 1183–1187.
Bonaduce D et al. Myocardial hypertrophy and left ventricular diastolic function in hypertensive patients: an echo Doppler evaluation. Eur Heart J 1989; 10: 611–621.
Weber KT, Brilla CG . Pathological hypertrophy and cardiac interstitium. Fibrosis and renin–angiotensin–aldosterone system. Circulation 1991; 83: 1849–1865.
Schmieder RE et al. Does the renin–angiotensin–aldosterone system modify cardiac structure and function in essential hypertension? Am J Med 1988; 84: 136–139.
Harrap SB et al. Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation 1996; 93: 1148–1154.
Malmqvist K et al. The renin–angiotensin system, sympathetic nervous system, insulin and leptin in relation to left ventricular mass. J Internal Med 2002; 252: 430–439.
Mureddu GF et al. Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity. Int J Obes Relat Metab Disord. 1998; 22: 363–368.
Wachtell K et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation 2002; 105: 1071–1076.
Reichek N, Devereux RB . Reliable estimation of peak left ventricular systolic pressure by M-mode echocardiographic-determined end-diastolic relative wall thickness: identification of severe valvular aortic stenosis in adult patients. Am Heart J 1982; 103: 202–209.
Wachtell K et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension 2000; 35: 6–12.
Verdecchia P et al. Asymmetric left ventricular remodeling due to isolated septal thickening in patients with systemic hypertension and normal left ventricular mass. Am J Cardiol 1994; 73: 247–252.
Wandt B, Bojo L, Tolagen K, Wranne B . Echocardiographic assessment of ejection fraction in left ventricular hypertrophy. Heart 1999; 82: 192–198.
Jones CJ, Raposo L, Gibson DG . Functional importance of the long axis dynamics of the human left ventricle. Br Heart J 1990; 63: 215–220.
Aurigemma GP, Silver KH, Priest MA, Gaasch WH . Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol 1995; 26: 195–202.
Licata G, Scaglione R, Parrinello G, Corrao S . Rapid left ventricular filling in untreated hypertensive subjects with or without left ventricular hypertrophy. Chest 1992; 102: 1507–1511.
Lutas EM et al. Increased cardiac performance in mild essential hypertension. Left ventricular mechanics. Hypertension 1985; 7: 979–988.
Hartford M et al. Left ventricular wall stress and systolic function in untreated primary hypertension. Hypertension 1985; 7: 97–104.
Gandhi SK et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001; 344: 17–22.
Vasan RS, Benjamin EJ, Levy D . Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995; 26: 1565–1574.
Schillaci G et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol 2002; 39: 2005–2011.
Bella JN et al. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation 2002; 105: 1928–1933.
Acknowledgements
We thank Ms A-M Ekman, A-C Kjerr, M Lundström and M Ring for expert technical assistance. This study was supported by Karolinska Institutet, Stockholm, Sweden, the Swedish Heart-Lung Foundation, the Swedish Society of Hypertension, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ, USA and Sanofi-Synthélabo, Paris, France.
Author information
Authors and Affiliations
Corresponding author
Additional information
Results from the Swedish irbesartan left ventricular hypertrophy investigation vs atenolol (SILVHIA)
Rights and permissions
About this article
Cite this article
Müller-Brunotte, R., Kahan, T., Malmqvist, K. et al. Blood pressure and left ventricular geometric pattern determine diastolic function in hypertensive myocardial hypertrophy. J Hum Hypertens 17, 841–849 (2003). https://doi.org/10.1038/sj.jhh.1001622
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001622
Keywords
This article is cited by
-
A comprehensive characterization of myocardial and vascular phenotype in pediatric chronic kidney disease using cardiovascular magnetic resonance imaging
Journal of Cardiovascular Magnetic Resonance (2018)
-
Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study
BMC Nephrology (2015)
-
Short‐term Training Effects on Diastolic Function in Obese Persons With the Metabolic Syndrome
Obesity (2008)
-
Short-term effects of cilazapril and atenolol on P-wave dispersion in patients with hypertension
Advances in Therapy (2008)
-
Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension
Advances in Therapy (2008)